Last reviewed · How we verify
NCT04529239
Type 2 Diabetes Glucose Biomarker Study With a Continuous Glucose Monitoring System
trial testing Abbott Freestyle Libre Pro in Healthy in 150 participants. Completed in 1 March 2022.
1 February 2022
Quick facts
| Lead sponsor | Klick Inc. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 31 August 2020 |
| Primary completion | 1 February 2022 |
| Estimated completion | 1 March 2022 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Abbott Freestyle Libre Pro
Conditions studied
- Healthy — all drugs for Healthy →
- Type 2 Diabetes Mellitus — all drugs for Type 2 Diabetes Mellitus →
Sponsor
Klick Inc.
Who can join
Adults 18 to 60, any sex, with Healthy or Type 2 Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Current gold standard methodologies for diagnosing type 2 diabetes (T2D) or prediabetes can be unreliable and inaccurate, and require the need for multiple different tests for comparison. It is possible that a simpler and more refined method of diagnosing T2D or prediabetes involves examining the proportional-integral (PI) control system of the body's glycemic function (i.e., a model of the glucose curve). The purpose of this research is to examine how well a PI model can diagnose nondiabetic, prediabetic, or diabetic patients based on glucose data gathered from a wearable glucose monitoring device.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Screening for Impaired Glucose Homeostasis: A Novel Metric of Glycemic Control.
Kaufman JM, van Veen L, Fossat Y. · · 2023 · cited 2× · PMID 40206722 · DOI 10.1016/j.mcpdig.2023.02.008
Verify or expand the search:
- PubMed search for NCT04529239
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Abbott Freestyle Libre Pro
Trials testing the same drug.
- NCT06473480 — Continuous Bloodsugar Monitoring System With a Sensor Compared to Fingerstick Bloodsugar Monitoring · NA · recruiting
- NCT03053518 — Validation of Machine Learning Based Personalized Nutrition Algorithm to Reduce Postprandial Glycemic Excursions Among N · NA · terminated
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Klick Inc. trials
Trials by the same sponsor.
- NCT04077203 — Biofeedback of Glucose in Non-diabetic Participants · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04529239 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Klick Inc.
- Last refreshed: 29 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04529239.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing